Bellicum制药(BLCM)

0.0747 0.0000 0.0%

今开:0.0昨收:0.07475
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:709848.0

Bellicum制药的热门讨论

tiger-in-motion2023-05-08 22:52

$Bellicum制药(BLCM)$ 大佬躬身入局买入10% ,我们小虾米跟进 买了6500

这个票严重低估,账面现金是今天市值的三倍
而且平台的技术授权最近收到500万美金,这还不包括利用该平台技术商业话的 抽成
太便宜了查看全文

冰雪爆2023-04-17 23:30

$Bellicum制药(BLCM)$ 啥情况?死而复生吗查看全文

超过5%股东持股披露

Bellicum制药(BLCM)2023-05-06 04:33

$Bellicum制药(BLCM)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-056574  Act: 34  Size: 139 KB 网页链接查看全文

志斌ox82023-04-18 00:22

$Bellicum制药(BLCM)$ 解套关注查看全文

当期报告

Bellicum制药(BLCM)2023-04-11 18:06

$Bellicum制药(BLCM)$ 8-K Current report, item 3.01 Accession Number: 0001628280-23-011198  Act: 34  Size: 187 KB 网页链接查看全文

超过5%股东持股披露「修订」

Bellicum制药(BLCM)2023-02-15 01:12

$Bellicum制药(BLCM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-23-001045  Act: 34  Size: 90 KB 网页链接查看全文

持股变动声明

Bellicum制药(BLCM)2022-09-02 22:36

$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-22-024218  Size: 4 KB 网页链接查看全文

超过5%股东持股披露「修订」

Bellicum制药(BLCM)2023-11-25 02:45

$Bellicum制药(BLCM)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-120984  Act: 34  Size: 219 KB 网页链接查看全文

持股变动声明

Bellicum制药(BLCM)2023-11-25 02:45

$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-056578  Size: 22 KB 网页链接查看全文

当期报告

Bellicum制药(BLCM)2023-11-22 21:35

$Bellicum制药(BLCM)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001628280-23-039830  Act: 34  Size: 808 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

Bellicum制药的公告

超过5%股东持股披露「修订」

$Bellicum制药(BLCM)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-120984  Act: 34  Size: 219 KB 网页链接

持股变动声明

$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-056578  Size: 22 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001628280-23-039830  Act: 34  Size: 808 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038953  Act: 34  Size: 4 MB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-23-033257  Act: 34  Size: 199 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 7.01 Accession Number: 0001628280-23-030016  Act: 34  Size: 186 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-028893  Act: 34  Size: 4 MB 网页链接

其他

$Bellicum制药(BLCM)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000485  Act: 34  Size: 3 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 5.02 Accession Number: 0001628280-23-020619  Act: 34  Size: 197 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 3.01 Accession Number: 0001628280-23-020109  Act: 34  Size: 198 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47